Showing results (1241-1250 of 1,367) with videos related to
Sort By:
Pageof 137
Schizophrenia Bulletin|September 1, 2011
Effect of DISC1 on the P300 waveform in psychosisMadiha Shaikh, Mei-Hua Hall, Katja Schulze, et al.Molecular Cancer Therapeutics|July 29, 2010
Selective and potent Raf inhibitors paradoxically stimulate normal cell proliferation and tumor growthJosette Carnahan, Pedro J Beltran, Carol Babij, et al.Annals of Internal Medicine|April 1, 1979
Sporadic community-acquired Legionnaires' disease in the United States. A case-control studyG Storch, W B Baine, D W Fraser, et al.Bioorganic & Medicinal Chemistry Letters|May 19, 2012
Discovery and optimization of a potent and selective triazolopyridinone series of c-Met inhibitorsChristiane M Bode, Alessandro A Boezio, Brian K Albrecht, et al.Breast Cancer Research : BCR|December 4, 2025
Secreted frizzled-related protein 2 monoclonal antibody-mediated IFN-ϒ reprograms tumor-associated macrophages to suppress triple negative breast cancerLillian Hsu, Julie Siegel, Patrick Nasarre, et al.Archives of General Psychiatry|September 10, 2003
Regionally localized thinning of the cerebral cortex in schizophreniaGina R Kuperberg, Matthew R Broome, Philip K McGuire, et al.Journal of Dental Education|September 23, 2023
Developing entrustable professional activities for general dentistry at the University of North CarolinaRocio B Quinonez, Angela Broome, Sam Nesbit, et al.Cancer Cell|December 3, 2016
CD98-Mediated Adhesive Signaling Enables the Establishment and Propagation of Acute Myelogenous LeukemiaJeevisha Bajaj, Takaaki Konuma, Nikki K Lytle, et al.Nature Communications|February 20, 2015
Capture Hi-C identifies the chromatin interactome of colorectal cancer risk lociRoland Jäger, Gabriele Migliorini, Marc Henrion, et al.Expert Review of Clinical Immunology|April 29, 2025
Safety profile of efgartigimod from global clinical trials across multiple immunoglobulin G-mediated autoimmune diseasesKelly G Gwathmey, Catherine M Broome, Matthias Goebeler, et al.Pageof 137